Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
A look ahead at the forecast for the Tyne Tees region.
Tony Blair's former bodyguard has been found guilty of benefit fraud after raking in tens of thousands of pounds in disability allowance.
A brand new £82 million train building factory is opening in Newton Aycliffe